Many states have legalized the recreational use of marijuana in recent years, creating one of the more radical cultural shifts the United States has seen in quite some time. What could this trend mean from a cardiologist's perspective?
Jeffrey Kuvin, MD, one of the leading voices behind the push for a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.
Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.
The popular AI chatbot's performance highlighted both its strengths and its weaknesses. It can answer multiple-choice questions, for example, but it struggles with consistency.
TAVR is also associated with a lower risk of acute kidney injury in this patient population. In-hospital mortality rates, however, are similar between the two treatment options.
Hospital employment models, reimbursement policies and private equity have all led to a massive reduction in the number of cardiologists working for a private practice, ACC President Cathie Biga, MSN, told Cardiovascular Business.
Healthcare technology companies can now use AFib findings recorded by an Apple Watch to help demonstrate the effectiveness of their devices to the FDA.
Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."